Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study

This 7-day randomized, double-blind, placebo-controlled fixed-dose study (NCT03766867) explored the potential for accelerating the onset of antidepressant efficacy of single-dose intravenous (IV) vortioxetine at oral vortioxetine treatment initiation. Patients (ages 18–65 years) hospitalized per sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Rancans, Elmars, Zambori, Janos, Dalsgaard, Mads, Baayen, Corine, Areberg, Johan, Ettrup, Anders, Florea, Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531504/
https://www.ncbi.nlm.nih.gov/pubmed/32784346
http://dx.doi.org/10.1097/YIC.0000000000000326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7531504/
https://www.ncbi.nlm.nih.gov/pubmed/32784346
http://dx.doi.org/10.1097/YIC.0000000000000326

Ejemplares similares